TrialHepatology international2020

Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.

Yi-Wen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.